Germany: Market for Medicaments Containing Corticosteroid Hormones 2025

Market Size for Medicaments Containing Corticosteroid Hormones in Germany

In 2021, after three years of growth, there was significant decline in the German medicaments containing corticosteroid hormones market, when its value decreased by -16.2% to $X. In general, consumption showed a slight contraction. As a result, consumption attained the peak level of $X, and then fell rapidly in the following year.

Production of Medicaments Containing Corticosteroid Hormones in Germany

In value terms, medicaments containing corticosteroid hormones production skyrocketed to $X in 2021 estimated in export price. Overall, the total production indicated a measured expansion from 2012 to 2021: its value increased at an average annual rate of +2.0% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production increased by +81.1% against 2019 indices. As a result, production reached the peak level and is likely to continue growth in the immediate term.

Exports of Medicaments Containing Corticosteroid Hormones

Exports from Germany

For the tenth consecutive year, Germany recorded growth in shipments abroad of medicaments containing corticosteroid hormones, which increased by 8.8% to X tons in 2021. Overall, total exports indicated a resilient increase from 2012 to 2021: its volume increased at an average annual rate of +6.4% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +74.6% against 2012 indices. The pace of growth was the most pronounced in 2016 with an increase of 12%. The exports peaked in 2021 and are expected to retain growth in the near future.

In value terms, medicaments containing corticosteroid hormones exports surged to $X in 2021. Over the period under review, total exports indicated a remarkable increase from 2012 to 2021: its value increased at an average annual rate of +8.1% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +92.8% against 2017 indices. The pace of growth was the most pronounced in 2020 with an increase of 28% against the previous year. The exports peaked in 2021 and are expected to retain growth in the near future.

Exports by Country

Italy (X tons), China (X tons) and Russia (X tons) were the main destinations of medicaments containing corticosteroid hormones exports from Germany, together comprising 21% of total exports. France, the Netherlands, Poland, the United States, Spain, Japan, the UK, Switzerland, Australia and Brazil lagged somewhat behind, together comprising a further 38%.

From 2012 to 2021, the biggest increases were recorded for Spain (with a CAGR of +19.3%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the United States ($X), Italy ($X) and the Netherlands ($X) appeared to be the largest markets for medicaments containing corticosteroid hormones exported from Germany worldwide, with a combined 42% share of total exports.

Italy, with a CAGR of +35.5%, saw the highest growth rate of the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average medicaments containing corticosteroid hormones export price stood at $X per ton in 2021, growing by 14% against the previous year. In general, export price indicated a modest expansion from 2012 to 2021: its price increased at an average annual rate of +1.6% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, medicaments containing corticosteroid hormones export price increased by +60.5% against 2017 indices. The most prominent rate of growth was recorded in 2020 an increase of 23%. The export price peaked at $X per ton in 2014; however, from 2015 to 2021, the export prices failed to regain momentum.

There were significant differences in the average prices for the major overseas markets. In 2021, the country with the highest price was the United States ($X per ton), while the average price for exports to Russia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Italy (+14.6%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports into Germany

Medicaments containing corticosteroid hormones imports into Germany rose modestly to X tons in 2021, surging by 4.8% compared with the year before. Over the period under review, total imports indicated a prominent increase from 2012 to 2021: its volume increased at an average annual rate of +8.6% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +10.1% against 2019 indices. The pace of growth appeared the most rapid in 2014 when imports increased by 33% against the previous year. Over the period under review, imports hit record highs at X tons in 2018; afterwards, it flattened through to 2021.

In value terms, medicaments containing corticosteroid hormones imports expanded notably to $X in 2021. Overall, imports saw a strong increase. The most prominent rate of growth was recorded in 2014 when imports increased by 23%. Imports peaked in 2021 and are expected to retain growth in the immediate term.

Imports by Country

Italy (X tons), France (X tons) and Belgium (X tons) were the main suppliers of medicaments containing corticosteroid hormones imports to Germany, with a combined 47% share of total imports. These countries were followed by Switzerland, the Netherlands, the UK, Sweden, Mexico, the Czech Republic, Spain, Poland, Denmark and Ireland, which together accounted for a further 46%.

From 2012 to 2021, the biggest increases were recorded for Mexico (with a CAGR of +235.7%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing corticosteroid hormones suppliers to Germany were Italy ($X), Belgium ($X) and Switzerland ($X), together accounting for 54% of total imports. These countries were followed by France, the Netherlands, Denmark, Poland, the Czech Republic, the UK, Sweden, Spain, Ireland and Mexico, which together accounted for a further 41%.

Mexico, with a CAGR of +193.3%, recorded the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average medicaments containing corticosteroid hormones import price stood at $X per ton in 2021, surging by 8.5% against the previous year. Over the last nine-year period, it increased at an average annual rate of +2.3%. The most prominent rate of growth was recorded in 2019 when the average import price increased by 19% against the previous year. Over the period under review, average import prices hit record highs in 2021 and is likely to continue growth in years to come.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Denmark ($X per ton), while the price for Mexico ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Belgium (+12.6%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :